Influenza Vaccine
Remaining flu shots directed to high-risk patients
Published in TB and Outbreaks Week, November 2nd, 2004
But only a fraction of the 22.4 million doses that maker Aventis Pasteur has yet to ship can be diverted to areas with the biggest shortages. And officials acknowledged that even if planned rationing goes well, there will be high-risk patients who struggle to get shots but can't find them.
"We're sorry for the people who need flu vaccine and may not be able to get it this year," said Julie Gerberding, MD, director of the Centers for Disease Control and Prevention (CDC). "But we will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bacterial Pathogen
Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria - Hepatitis C Virus Infection
Persistence of hepatitis C virus associated with human leukocyte antigen class 1 - Influenza Virus
Antigenically and genetically similar influenza C viruses in Japan characterized - Meningitis Outbreak
Nosocomial meningitis outbreak caused by Acinetobacter baumannii - SARS Infection Control
Providing SARS infection control information to outpatients increases compliance - AIDS/HIV Diagnosis
HIV-1 superinfections assessed by autologous heteroduplex mobility - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
